Incidence and clinicopathological characteristics of intraductal carcinoma detected in prostate biopsies: A prospective cohort study

Histopathology

Volumn 63, Issue 4, 2013, Pages 574-579

  Watts, Katherine ^a   Li, Jianbo ^b   Magi Galluzzi, Cristina ^a   Zhou, Ming ^a,c  

^a Pathology and Laboratory Medicine Institute   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Biopsy; Intraductal carcinoma; Prognosis; Prostate cancer

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; BRACHYTHERAPY; CANCER DIAGNOSIS; CANCER INCIDENCE; COHORT ANALYSIS; EXTERNAL BEAM RADIOTHERAPY; GLEASON SCORE; HUMAN; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CARCINOMA; PROSTATE INTRADUCTAL CARCINOMA; PROSTATECTOMY; SEMINAL VESICLE;

BIOPSY; INTRADUCTAL CARCINOMA; PROGNOSIS; PROSTATE CANCER;

AGED; BIOPSY; CARCINOMA, DUCTAL; COHORT STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS;

EID: 84884723631     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12198     Document Type: Article

References (22)

1. Kovi J, Jackson MA, Heshmat MY. Ductal spread in prostatic adenocarcinoma. Cancer 1985; 56; 1566-1573.
2. McNeal JE, Yemoto CE. Spread of adenocarcinoma within prostatic ducts and acini. Morphologic and clinical correlations. Am. J. Surg. Pathol. 1996; 20; 802-814.
3. Cohen RJ, McNeal JE, Baillie T. Patterns of differentiation and proliferation in intraductal carcinoma of the prostate: significance for cancer progression. Prostate 2000; 43; 11-19.
4. Rubin MA, de La Taille A, Bagiella E et al. Cribriform carcinoma of the prostate and cribriform prostatic intraepithelial neoplasia: incidence and clinical implications. Am. J. Surg. Pathol. 1998; 22; 840-848.
5. Wilcox G, Soh S, Charkraborty S et al. Patterns of high-grade prostatic intraepithelial neoplasia associated with clinically aggressive prostate cancer. Hum. Pathol. 1998; 29; 1119-1123.
6. Dawkins HJ, Selner LN, Turbett GR et al. Distinction between intraductal carcinoma of the prostate (IDC-P), high-grade dysplasia (PIN), and invasive prostatic adenocarcinoma, using molecular markers of cancer progression. Prostate 2000; 44; 265-270.
7. Shah RB, Magi-Galluzzi C, Han B et al. Atypical cribriform lesions of the prostate: relationship to prostatic carcinoma and implications for diagnosis in prostate biopsies. Am. J. Surg. Pathol. 2010; 34; 470-477.
8. Cohen RJ, Chan WC, Edgar SG et al. Prediction of pathological stage and clinical outcome in prostate cancer: an improved pre-operative model incorporating biopsy-determined intraductal carcinoma. Br. J. Urol. 1998; 81; 413-418.
9. O'Brien BA, Cohen RJ, Wheeler TM et al. A post-radical-prostatectomy nomogram incorporating new pathological variables and interaction terms for improved prognosis. BJU Int. 2011; 107; 389-395.
10. Efstathiou E, Abrahams N, Tibbs NA et al. Morphologic characterization of preoperatively treated prostate cancer: toward a post-therapy histologic classification. Eur. Urol. 2010; 57; 1030-1038.
11. Van der Kwast T, Al Daoud N, Collette L et al. Biopsy diagnosis of of intraductal carcinoma is prognostic in intermediate and high risk prostate cancer patients treated by radiotherapy. Eur. J. Cancer 2012; 48; 1318-1325.
12. Guo CC, Epstein JI. Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance. Mod. Pathol. 2006; 19; 1528-1535.
13. Robinson BD, Epstein JI. Intraductal carcinoma of the prostate without invasive carcinoma on needle biopsy: emphasis on radical prostatectomy findings. J. Urol. 2010; 184; 1328-1333.
14. Humphrey PA. Histological variants of prostatic carcinoma and their significance. Histopathology 2012; 60; 59-74.
15. Epstein JI, Allsbrook WC Jr, Amin MB et al. The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason Grading of prostatic carcinoma. Am. J. Surg. Pathol. 2005; 29; 1228-1242.
16. Latour M, Amin MB, Billis A et al. Grading of invasive cribriform carcinoma on prostate needle biopsy: an interobserver study among experts in genitourinary pathology. Am. J. Surg. Pathol. 2008; 32; 1532-1539.
17. Partin AW, Kattan MW, Subong EN et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA 1997; 277; 1445-1451.
18. Partin AW, Yoo J, Carter HB et al. The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J. Urol. 1993; 150; 110-114.
19. Partin AW, Mangold LA, Lamm DM et al. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. Urology 2001; 58; 843-848.
20. Robinson B, Magi-Galluzzi C, Zhou M. Intraductal carcinoma of the prostate. Arch. Pathol. Lab. Med. 2012; 136; 418-425.
21. Montironi R, Scarpelli M, Cheng L et al. Do not misinterpret intraductal carcinoma of the prostate as high grade prostatic intraepithelial neoplasia!. Eur. Urol. 2012; 62; 518-522.
22. Bonkhoff H, Wheeler TM, Van der Kwast TH et al. Intraductal carcinoma of the prostate: precursor or aggressive phenotype of prostate cancer? Prostate 2013; 73; 442-448.